Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

1st Jul 2013 16:55

RNS Number : 3347I
GlaxoSmithKline PLC
01 July 2013
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 28 June 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

 

 

Ordinary Shares

ADSs

Sir Andrew Witty

6,151.624

Dr M M Slaoui

1,897.363

Mr S Dingemans

2,706.794

Mr S M Bicknell

591.492

Mr R G Connor

1,159.796

Mrs D P Connelly

785.783

Mr S A Hussain

2,319.605

Mr W C Louv

556.586

Mr D S Redfern

889.177

Ms C Thomas

1,256.452

Mr P C Thomson

599.221

Mr D E Troy

1,187.662

Dr P J T Vallance

2,706.218

Ms E Walmsley

1,546.408

Mr C Weber

552.523

Mrs V A Whyte

165.826

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.

 

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

1 July 2013

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBXDFEBBL

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77